LLY compared with ENTA: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

ENTAEnanta Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

ENTAEnanta Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

ENTA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±19.1%▼−2.10%×0.11

Q2 FY26±19.0%▼−6.02%×0.32

= impliedLLY realized, solidENTA realized, hatchedOne scale, both sides: full bar = 20%× = |realized| ÷ impliedSource: market data

Q1 FY26

±13.1%

▲+2.17%

×0.17

Nov 18 '25±17.1%▼−3.59%×0.21

LLYELI Lilly & Co

1,364.63▼−0.01%

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

ENTAEnanta Pharmaceuticals Inc

10.29▲+2.08%

Regular sessionNov 6 '26

Mkt cap$293.6MRevenue$14MQ3 FY26Revenue$67MFY24

Compare

Regular sessionNov 6 '26

LLYELI Lilly & Co

ENTAEnanta Pharmaceuticals Inc

1,364.63▼−0.01%

Price

10.29▲+2.08%

$1.2T

Mkt cap

$293.6M

Q3 FY26$24.4B

Revenue

$14MQ3 FY26

FY25$65.2B

Revenue

$67MFY24

LLY1,364.63▼−0.01%vsENTA10.29▲+2.08%Regular sessionNov 6 '26